DongKook Life Science동국생명과학
303810 · KOSDAQ · ₩303810 · 동국생명과학
₩2,095▼ ₩50 (2.33%)End-of-day · Oct 30, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Gross margin | 25.3% | 25.3% | 21.7% |
| Operating margin | 8.7% | 10.0% | 9.0% |
| Net margin | 4.2% | 6.6% | 1.7% |
Growth (year on year)
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Revenue growth | −9.7% | −1.1% | — |
| Operating income growth | −21.9% | +9.5% | — |
| Net income growth | −43.2% | +285.7% | — |
Returns
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Return on equity | 3.7% | 7.3% | 2.1% |
| Return on assets | 2.3% | 4.2% | 1.2% |
Leverage and liquidity
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Liabilities to equity | 64.0% | 65.7% | 82.1% |
| Net debt to equity | — | 27.7% | 38.7% |
| Current ratio | 172.9% | 171.8% | 183.9% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: DongKook Life Science / 동국생명과학 / 303810 / KRX:303810
Source: KRX statistical information